Delivery Order SPE2DB25D3201-SPE2DB25FNWPB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,516.87 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract. The award was issued on June 20, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement through DLA's medical supply chain, with performance to occur at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $5,562.44 delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,432.41 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is a child contract executed under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order valued at $68,123.33 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100s). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 11, 2025. The award was made without a set-aside designation, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,200.66 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWPBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,265.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed price contract. This non-set-aside award was executed on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this delivery order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply needs through AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 prime IDC vehicle (SPE2DX), which runs through December 2026. The contract reflects the company's established capability to competitively deliver pharmaceutical products across multiple therapeutic domains to military and veteran healthcare systems on a global scale. Rifampin, an antibiotic medication, represents the type of critical pharmaceutical commodity that supports military medical operations and readiness across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 9/15/25 |